{"pmid":32336170,"title":"Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female.","text":["Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female.","Seven species of coronavirus cause of acute respiratory illness in humans. Coronavirus HKU 1 (CoV-HKU 1) was first described in 2005 in an adult patient with pneumonia in Hong Kong. Although it is a well-known respiratory tract pathogen, there is not much information about its role in hospitalized adults, especially in southern Europe. Here we describe a case of radiologically demonstrated CoV-HKU 1-related bronchiolitis with acute respiratory failure in an adult female without significant comorbidities except obesity.","J Asthma","Bianchi, Francesco","Bennett, David","Alderighi, Lorenzo","Pieroni, Maria","Refini, Rosa Metella","Fossi, Antonella","Bargagli, Elena","Mazzei, Maria Antonietta","Guazzi, Gianni","Cusi, Maria Grazia","Sestini, Piersante","32336170"],"abstract":["Seven species of coronavirus cause of acute respiratory illness in humans. Coronavirus HKU 1 (CoV-HKU 1) was first described in 2005 in an adult patient with pneumonia in Hong Kong. Although it is a well-known respiratory tract pathogen, there is not much information about its role in hospitalized adults, especially in southern Europe. Here we describe a case of radiologically demonstrated CoV-HKU 1-related bronchiolitis with acute respiratory failure in an adult female without significant comorbidities except obesity."],"journal":"J Asthma","authors":["Bianchi, Francesco","Bennett, David","Alderighi, Lorenzo","Pieroni, Maria","Refini, Rosa Metella","Fossi, Antonella","Bargagli, Elena","Mazzei, Maria Antonietta","Guazzi, Gianni","Cusi, Maria Grazia","Sestini, Piersante"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336170","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/02770903.2020.1761981","keywords":["acute respiratory failure","bronchiolitis","coronavirus","virus infection"],"locations":["China","obese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1665264685603094528,"score":8.574329,"similar":[{"pmid":32248675,"title":"Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","text":["Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study","Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness.","Crit Care Resusc","Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D","32248675"],"abstract":["Objective: To report the first eight cases of critically ill patients with coronavirus disease 2019 (COVID-19) in Hong Kong, describing the treatments and supportive care they received and their 28-day outcomes. Design: Multicentre retrospective observational cohort study. Setting: Three multidisciplinary intensive care units (ICUs) in Hong Kong. Participants: All adult critically ill patients with confirmed COVID-19 admitted to ICUs in Hong Kong between 22 January and 11 February 2020. Main outcome measure: 28-day mortality. Results: Eight out of 49 patients with COVID-19 (16%) were admitted to Hong Kong ICUs during the study period. The median age was 64.5 years (range, 42-70) with a median admission Sequential Organ Failure Assessment (SOFA) score of 6 (IQR, 4-7). Six patients (75%) required mechanical ventilation, six patients (75%) required vasopressors and two (25%) required renal replacement therapy. None of the patients required prone ventilation, nitric oxide or extracorporeal membrane oxygenation. The median times to shock reversal and extubation were 9 and 11 days respectively. At 28 days, one patient (12%) had died and the remaining seven (88%) all survived to ICU discharge. Only one of the survivors (14%) still required oxygen at 28 days. Conclusion: Critically ill patients with COVID-19 often require a moderate duration of mechanical ventilation and vasopressor support. Most of these patients recover and survive to ICU discharge with supportive care using lung protective ventilation strategies, avoiding excess fluids, screening and treating bacterial co-infection, and timely intubation. Lower rather than upper respiratory tract viral burden correlates with clinical severity of illness."],"journal":"Crit Care Resusc","authors":["Ling, Lowell","So, Christina","Shum, Hoi Ping","Chan, Paul K S","Lai, Christopher K C","Kandamby, Darshana H","Ho, Eunise","So, Dominic","Yan, Wing Wa","Lui, Grace","Leung, Wai Shing","Chan, Man Chun","Gomersall, Charles D"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32248675","week":"202015|Apr 06 - Apr 12","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"e_drugs":["Nitric Oxide"],"_version_":1663352136279261184,"score":112.37671},{"pmid":32310715,"title":"Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).","text":["Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).","Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated viral infection (coronavirus disease 2019, COVID-19) is a virulent, contagious viral pandemic that is affecting populations worldwide. As with any airborne viral respiratory infection, surgical and non-surgical patients may be affected. Methods: Review and synthesis of pertinent English-language literature pertaining to COVID-19 infection among adult patients. Results: COVID-19 disease that requires hospitalization results in critical illness approximately 25% of the time and requires mechanical ventilation with positive airway pressure. Acute kidney injury, a marked hypercoagulable state, and sometimes myocarditis can be features of COVID-19 in addition to the characteristic severe acute lung injury. Even if not among the most seriously afflicted, older patients with medical comorbidities are both predisposed to infection and risk increased morbidity and mortality, however, all persons presenting for surgical intervention should be suspected of infection (and thus transmissibility) even if asymptomatic. Although most elective surgery has been curtailed by administrative or governmental fiat, patients will still need urgent or emergency operative intervention for time-sensitive disease processes such as malignant neoplasia or for true emergencies such as perforated viscus or traumatic injury. It is possible to provide safe surgical care for SARS-CoV-2-positive patients and minimize nosocomial transmission to healthcare workers. Conclusions: This guidance will facilitate appropriate protection of patients and staff, and maintenance of infection control measures to assist surgical personnel and facilities to prepare for COVID-19-infected adult patients requiring urgent or emergent operative intervention and to provide optimal patient care.","Surg Infect (Larchmt)","Heffernan, Daithi S","Evans, Heather L","Huston, Jared M","Claridge, Jeffrey A","Blake, David P","May, Addison K","Beilman, Greg S","Barie, Philip S","Kaplan, Lewis J","32310715"],"abstract":["Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated viral infection (coronavirus disease 2019, COVID-19) is a virulent, contagious viral pandemic that is affecting populations worldwide. As with any airborne viral respiratory infection, surgical and non-surgical patients may be affected. Methods: Review and synthesis of pertinent English-language literature pertaining to COVID-19 infection among adult patients. Results: COVID-19 disease that requires hospitalization results in critical illness approximately 25% of the time and requires mechanical ventilation with positive airway pressure. Acute kidney injury, a marked hypercoagulable state, and sometimes myocarditis can be features of COVID-19 in addition to the characteristic severe acute lung injury. Even if not among the most seriously afflicted, older patients with medical comorbidities are both predisposed to infection and risk increased morbidity and mortality, however, all persons presenting for surgical intervention should be suspected of infection (and thus transmissibility) even if asymptomatic. Although most elective surgery has been curtailed by administrative or governmental fiat, patients will still need urgent or emergency operative intervention for time-sensitive disease processes such as malignant neoplasia or for true emergencies such as perforated viscus or traumatic injury. It is possible to provide safe surgical care for SARS-CoV-2-positive patients and minimize nosocomial transmission to healthcare workers. Conclusions: This guidance will facilitate appropriate protection of patients and staff, and maintenance of infection control measures to assist surgical personnel and facilities to prepare for COVID-19-infected adult patients requiring urgent or emergent operative intervention and to provide optimal patient care."],"journal":"Surg Infect (Larchmt)","authors":["Heffernan, Daithi S","Evans, Heather L","Huston, Jared M","Claridge, Jeffrey A","Blake, David P","May, Addison K","Beilman, Greg S","Barie, Philip S","Kaplan, Lewis J"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310715","week":"202017|Apr 20 - Apr 26","doi":"10.1089/sur.2020.101","keywords":["covid-19","sars-cov-2","sis","guidelines","pandemic","virus infection"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["neoplasia"],"_version_":1664632501378744321,"score":107.56482},{"pmid":32112966,"pmcid":"PMC7110436","title":"2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.","text":["2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.","INTRODUCTION: Several recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar to those seen previously in SARS-CoV and MERS-CoV infected patients. OBJECTIVE: We present some remarkable imaging findings of the first two patients identified in Italy with COVID-19 infection travelling from Wuhan, China. The follow-up with chest X-Rays and CT scans was also included, showing a progressive adult respiratory distress syndrome (ARDS). RESULTS: Moderate to severe progression of the lung infiltrates, with increasing percentage of high-density infiltrates sustained by a bilateral and multi-segmental extension of lung opacities, were seen. During the follow-up, apart from pleural effusions, a tubular and enlarged appearance of pulmonary vessels with a sudden caliber reduction was seen, mainly found in the dichotomic tracts, where the center of a new insurgent pulmonary lesion was seen. It could be an early alert radiological sign to predict initial lung deterioration. Another uncommon element was the presence of mediastinal lymphadenopathy with short-axis oval nodes. CONCLUSIONS: Although only two patients have been studied, these findings are consistent with the radiological pattern described in literature. Finally, the pulmonary vessels enlargement in areas where new lung infiltrates develop in the follow-up CT scan, could describe an early predictor radiological sign of lung impairment.","Int J Infect Dis","Albarello, Fabrizio","Pianura, Elisa","Di Stefano, Federica","Cristofaro, Massimo","Petrone, Ada","Marchioni, Luisa","Palazzolo, Claudia","Schinina, Vincenzo","Nicastri, Emanuele","Petrosillo, Nicola","Campioni, Paolo","Eskild, Petersen","Zumla, Alimuddin","Ippolito, Giuseppe","32112966"],"abstract":["INTRODUCTION: Several recent case reports have described common early chest imaging findings of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be similar to those seen previously in SARS-CoV and MERS-CoV infected patients. OBJECTIVE: We present some remarkable imaging findings of the first two patients identified in Italy with COVID-19 infection travelling from Wuhan, China. The follow-up with chest X-Rays and CT scans was also included, showing a progressive adult respiratory distress syndrome (ARDS). RESULTS: Moderate to severe progression of the lung infiltrates, with increasing percentage of high-density infiltrates sustained by a bilateral and multi-segmental extension of lung opacities, were seen. During the follow-up, apart from pleural effusions, a tubular and enlarged appearance of pulmonary vessels with a sudden caliber reduction was seen, mainly found in the dichotomic tracts, where the center of a new insurgent pulmonary lesion was seen. It could be an early alert radiological sign to predict initial lung deterioration. Another uncommon element was the presence of mediastinal lymphadenopathy with short-axis oval nodes. CONCLUSIONS: Although only two patients have been studied, these findings are consistent with the radiological pattern described in literature. Finally, the pulmonary vessels enlargement in areas where new lung infiltrates develop in the follow-up CT scan, could describe an early predictor radiological sign of lung impairment."],"journal":"Int J Infect Dis","authors":["Albarello, Fabrizio","Pianura, Elisa","Di Stefano, Federica","Cristofaro, Massimo","Petrone, Ada","Marchioni, Luisa","Palazzolo, Claudia","Schinina, Vincenzo","Nicastri, Emanuele","Petrosillo, Nicola","Campioni, Paolo","Eskild, Petersen","Zumla, Alimuddin","Ippolito, Giuseppe"],"date":"2020-03-01T11:00:00Z","year":2020,"_id":"32112966","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.ijid.2020.02.043","keywords":["covid-19","ct-scan","crazy-paving","enlarged pulmonary vessels","ground glass opacities","sars-cov2"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Italy","Wuhan","China","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"_version_":1664640875074945024,"score":103.435295},{"pmid":32179908,"title":"A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage.","text":["A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage.","Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were mainly based on information from adult populations. Limited data are available for children with COVID-19, especially for infected infants. We report a 55-day-old case with COVID-19 confirmed in China and describe the identification, diagnosis, clinical course, and treatment of the patient, including the disease progression from day 7 to day 11 of illness. This case highlights that children with COVID-19 can also present with multiple organ damage and rapid disease changes. When managing such patients, frequent and careful clinical monitoring is essential.","J Infect Dis","Cui, Yuxia","Tian, Maolu","Huang, Dong","Wang, Xike","Huang, Yuying","Fan, Li","Wang, Liang","Chen, Yun","Liu, Wenpu","Zhang, Kai","Wu, Yue","Yang, Zhenzhong","Tao, Jing","Feng, Jie","Liu, Kaiyu","Ye, Xianwei","Wang, Rongpin","Zhang, Xiangyan","Zha, Yan","32179908"],"abstract":["Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were mainly based on information from adult populations. Limited data are available for children with COVID-19, especially for infected infants. We report a 55-day-old case with COVID-19 confirmed in China and describe the identification, diagnosis, clinical course, and treatment of the patient, including the disease progression from day 7 to day 11 of illness. This case highlights that children with COVID-19 can also present with multiple organ damage and rapid disease changes. When managing such patients, frequent and careful clinical monitoring is essential."],"journal":"J Infect Dis","authors":["Cui, Yuxia","Tian, Maolu","Huang, Dong","Wang, Xike","Huang, Yuying","Fan, Li","Wang, Liang","Chen, Yun","Liu, Wenpu","Zhang, Kai","Wu, Yue","Yang, Zhenzhong","Tao, Jing","Feng, Jie","Liu, Kaiyu","Ye, Xianwei","Wang, Rongpin","Zhang, Xiangyan","Zha, Yan"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32179908","week":"202012|Mar 16 - Mar 22","doi":"10.1093/infdis/jiaa113","keywords":["covid-19 pneumonia","heart damage","liver injury"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874603085824,"score":97.46748},{"pmid":32104915,"title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","text":["The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.","Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure.","J Med Virol","Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu","32104915"],"abstract":["Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic coronavirus named SARS-CoV-2 (previously known as 2019-nCoV) emerged in December 2019 in Wuhan, China, and rapidly spreads around the world. This virus shares highly homological sequence with SARS-CoV, and causes acute, highly lethal pneumonia coronavirus disease 2019 (COVID-19) with clinical symptoms similar to those reported for SARS-CoV and MERS-CoV. The most characteristic symptom of patients with COVID-19 is respiratory distress, and most of the patients admitted to the intensive care could not breathe spontaneously. Additionally, some patients with COVID-19 also showed neurologic signs, such as headache, nausea, and vomiting. Increasing evidence shows that coronaviruses are not always confined to the respiratory tract and that they may also invade the central nervous system inducing neurological diseases. The infection of SARS-CoV has been reported in the brains from both patients and experimental animals, where the brainstem was heavily infected. Furthermore, some coronaviruses have been demonstrated able to spread via a synapse-connected route to the medullary cardiorespiratory center from the mechanoreceptors and chemoreceptors in the lung and lower respiratory airways. Considering the high similarity between SARS-CoV and SARS-CoV2, it remains to make clear whether the potential invasion of SARS-CoV2 is partially responsible for the acute respiratory failure of patients with COVID-19. Awareness of this may have a guiding significance for the prevention and treatment of the SARS-CoV-2-induced respiratory failure."],"journal":"J Med Virol","authors":["Li, Yan-Chao","Bai, Wan-Zhu","Hashikawa, Tsutomu"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104915","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25728","keywords":["cell susceptibility","coronavirus","dissemination","nervous system"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["Wuhan","China","SARS-CoV"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875129470976,"score":90.724236}]}